According to the research report, the global healthcare contract development and manufacturing organization market size is expected to touch USD 456.8 Billion by 2030, from USD 242.84 Billion in 2022, growing with a significant CAGR of 8.2% from 2022 to 2030.
The healthcare contract development and
manufacturing organization report offers a comprehensive study of the current
state expected at the major drivers, market strategies, and key vendors’
growth. The report presents energetic visions to conclude and study the market
size, market hopes, and competitive surroundings. The research also focuses on
the important achievements of the market, research & development, and
regional growth of the leading competitors operating in the market. The current
trends of the global healthcare contract development and manufacturing
organization in conjunction with the geographical landscape of this vertical
have also been included in this report.
The report offers intricate dynamics about
different aspects of the global healthcare contract development and manufacturing
organization market, which aids companies operating in the market in making
strategic development decisions. The study also elaborates on significant
changes that are highly anticipated to configure growth of the global healthcare
contract development and manufacturing organization during the forecast period.
It also includes a key indicator assessment that highlights growth prospects of
this market and estimates statistics related to growth of the market in terms
of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1615
| Report Coverage | Details |
| Market Size by 2030 | USD 456.8 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 8.2% |
| North America Market Share in 2021 | 41.5% |
| Contract Manufacturing Market Share in 2021 | 74% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Service, Geography |
This study covers a detailed segmentation
of the global healthcare contract development and manufacturing organization market,
along with key information and a competition outlook. The report mentions
company profiles of players that are currently dominating the global healthcare
contract development and manufacturing organization market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- Flex
- Covance Inc.
- Lonza Group Ltd.
- Thermo Fisher Scientific Inc.
- Jabil
- Catalent Inc.
- Sanmina Corporation
- IQVIA Holdings Inc.
- Siegfried Holding AG
- Recipharm AB
Market Segmentation
- Contract Manufacturing
- Small Molecule
- Preclinical
- Bioanalysis and DMPK studies
- Toxicology Testing
- Other Preclinical Services
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Laboratory Services
- Bioanalytical Services
- Analytical Services
- Large Molecule
- Cell Line development
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- MABs
- Recombinant proteins
- Others
- Others
- Contract Development
- Small Molecule
- Large Molecule
- MABs
- Recombinant proteins
- Others
- High Potency API
- Finished Dose Formulations
- Solid Dose Formulation
- Liquid Dose Formulation
- Injectable Dose Formulation
- Medical Devices
- Class I
- Class II
- Class III
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global healthcare contract development and
manufacturing organization report is based on detailed primary as well as
secondary research. With the help of in-depth insights of the market-affiliated
information that is obtained and legitimated by market-admissible resources,
analysts have offered riveting observations and authentic forecasts for the
global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global healthcare contract development and manufacturing organization market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Healthcare Contract Development and Manufacturing Organization Market
5.1. COVID-19 Landscape: Healthcare Contract Development and Manufacturing Organization Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Healthcare Contract Development and Manufacturing Organization Market, By Services
8.1. Healthcare Contract Development and Manufacturing Organization Market, by Services Type, 2020-2030
8.1.1. Contract Manufacturing
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Contract Development
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Healthcare Contract Development and Manufacturing Organization Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.3. France
9.2.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.4. Rest of Europe
9.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Services (2017-2030)
Chapter 10. Company Profiles
10.1. Flex
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Covance Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Lonza Group Ltd.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Thermo Fisher Scientific Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Jabil
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Catalent Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Sanmina Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. IQVIA Holdings Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments